Regulatory Approvals

FDA Approval on the Horizon for Anito-cel in Multiple Myeloma

By

Regulatory Approvals — FDA Approval on the Horizon for Anito-cel in Multiple Myeloma  Targeted Oncology

Read the original at Regulatory Approvals ↗

Auto-published by the finit.news Events monitor from Regulatory Approvals; summarized by AI and may contain errors — verify against the primary source. October 4, 2026.

By

Related Post

Regulatory Approvals

FDA approves 1st-of-its-kind pill to reduce cholesterol

Regulatory Approvals

FDA Approves Pirtobrutinib for First-Line CLL/SLL Without 17p Deletion, a First for Non-Covalent BTK Inhibitors

Regulatory Approvals

FDA approves Ponlimsi, a biosimilar for preventing fractures in prostate and breast cancer patients

Financial News For All

Business Economy Finance

Commodities Price Update: Crude Oil $91.11, Brent $102.25, Copper $6.55, Coal $104.75 — Oct 4, 2026 8:00 AM EDT

Product Recalls

WinCo Foods of Boise, ID is Recalling the Following Salsa Bean Dip Trays Due to the Inclusion of Recalled Peperoncini from G.L. Mezzetta

Product Recalls

Greenwich Rx Issues Voluntary Nationwide Recall of Compounded Glutathione Due to Elevated Endotoxin Levels

Product Recalls

Frutas y Hortalizas del Sur S.A. Expands Recalls to Include Additional Lots of Great Value Frozen Organic Triple Berry Blend 10 OZ, Great Value Frozen Organic Blueberries 10 OZ and One Lot of Trader Joe’s Frozen Organic Mixed Berry Blend 12 OZ Because of Potential Contamination with E. coli O145